Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and IrinotecanChiara Cremolini, Daniele Santini, Adele Busico et al.|JAMA Oncology|2018Cited by 418
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)Mohamed A. Gouda, Vivek Subbiah, Filip Jankú et al.|Annals of Oncology|2023Cited by 103
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus reportFederica Miglietta, Grazia Arpino, Maria Grazia Razeti et al.|Critical Reviews in Oncology/Hematology|2025Cited by 4